Welcome to our dedicated page for Global Innovative Platforms SEC filings (Ticker: GIPL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Global Innovative Platforms Inc. filings document its VOCAM Plus breathomics diagnostic technology, Regulation FD investor presentations, and material agreements involving diagnostic units and related support services. The company’s Form 8-K disclosures also cover analytical findings related to canine heartworm breath profiles and corporate matters such as changes in its certifying accountant.
Additional filings include Form 12b-25 late-filing notices for annual reporting, emerging growth company status disclosures, and statements that the company has no securities registered under Section 12(b) of the Exchange Act.
Global Innovative Platforms Inc. furnished an updated investor presentation and posted it on its website on September 26, 2025. The presentation, which outlines information for current and potential investors, is available under the Investor Relations section of www.vetbreath.com and is also provided as Exhibit 99.1 to a current report. The materials are being shared for informational purposes and are designated as furnished rather than filed under securities laws.